相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Improved hemodynamic and liver function in portal hypertensive cirrhotic rats after administration of B. pseudocatenulatum CECT 7765
Isabel Gomez-Hurtado et al.
EUROPEAN JOURNAL OF NUTRITION (2019)
Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension
Guadalupe Garcia-Tsao et al.
HEPATOLOGY (2019)
4 in 1: Antibody-free protocol for isolating the main hepatic cells from healthy and cirrhotic single rat livers
Anabel Fernandez-Iglesias et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
Rohit Loomba et al.
HEPATOLOGY (2018)
The portal hypertension syndrome: etiology, classification, relevance, and animal models
Jaime Bosch et al.
HEPATOLOGY INTERNATIONAL (2018)
Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis
Jose I. Fortea et al.
LIVER INTERNATIONAL (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Establishment of practical recellularized liver graft for blood perfusion using primary rat hepatocytes and liver sinusoidal endothelial cells
H. Kojima et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis
Steven P. Grover et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Resemblance of the human liver sinusoid in a fluidic device with biomedical and pharmaceutical applications
Marti Ortega-Ribera et al.
BIOTECHNOLOGY AND BIOENGINEERING (2018)
Pharmacokinetics and tolerability of semaglutide in people with hepatic impairment
Lene Jensen et al.
DIABETES OBESITY & METABOLISM (2018)
Stem cells as a new therapeutic strategy for portal hypertension and cirrhosis
A. Fernandez-Iglesias et al.
JOURNAL OF HEPATOLOGY (2018)
Effects of aging on liver microcirculatory function and sinusoidal phenotype
Raquel Maeso-Diaz et al.
AGING CELL (2018)
Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension
Dinesh Mani Tripathi et al.
GASTROENTEROLOGY (2018)
Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension
R. Schwarzer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial
Philip Noel Newsome et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Changing Concepts of Cirrhotic Coagulopathy
Armando Tripodi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis
Andrea De Gottardi et al.
LIVER INTERNATIONAL (2017)
Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis
Sabela Lens et al.
GASTROENTEROLOGY (2017)
Effects of an Intensive Lifestyle Intervention Program on Portal Hypertension in Patients With Cirrhosis and Obesity: The SportDiet Study
Annalisa Berzigotti et al.
HEPATOLOGY (2017)
The Anticoagulant Rivaroxaban Lowers Portal Hypertension in Cirrhotic Rats Mainly by Deactivating Hepatic Stellate Cells
Marina Vilaseca et al.
HEPATOLOGY (2017)
Cross-talk between autophagy and KLF2 determines endothelial cell phenotype and microvascular function in acute liver injury
Sergi Guixe-Muntet et al.
JOURNAL OF HEPATOLOGY (2017)
Liver sinusoidal endothelial cells: Physiology and role in liver diseases
Johanne Poisson et al.
JOURNAL OF HEPATOLOGY (2017)
The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction
Philipp Schwabl et al.
JOURNAL OF HEPATOLOGY (2017)
Loss of fatty acid binding protein-1 alters the hepatic endocannabinoid system response to a high-fat diet
Gregory G. Martin et al.
JOURNAL OF LIPID RESEARCH (2017)
Mimicking liver sinusoidal structures and functions using a 3D-configured microfluidic chip
Yu Du et al.
LAB ON A CHIP (2017)
Mitochondria-targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats
Marina Vilaseca et al.
LIVER INTERNATIONAL (2017)
Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studies
Fernanda Cristina de Mesquita et al.
SCIENTIFIC REPORTS (2017)
Rapid production of human liver scaffolds for functional tissue engineering by high shear stress oscillation-decellularization
Giuseppe Mazza et al.
SCIENTIFIC REPORTS (2017)
A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1
Nikki Buijs et al.
ANGIOGENESIS (2017)
Anticoagulation in cirrhosis: a new paradigm?
Filippo Leonardi et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2017)
How to Face Chronic Liver Disease: The Sinusoidal Perspective
Anabel Fernandez-Iglesias et al.
FRONTIERS IN MEDICINE (2017)
The New-Generation Pan-Peroxisome Proliferator-Activated Receptor Agonist IVA337 Protects the Liver From Metabolic Disorders and Fibrosis
Guillaume Wettstein et al.
HEPATOLOGY COMMUNICATIONS (2017)
Functionality based method for simultaneous isolation of rodent hepatic sinusoidal cells
L. Stradiot et al.
BIOMATERIALS (2017)
Caveolin 1 and G-Protein-Coupled Receptor Kinase-2 Coregulate Endothelial Nitric Oxide Synthase Activity in Sinusoidal Endothelial Cells
Songling Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Design and fabrication of a scalable liver-lobule-on-a-chip microphysiological platform
Amin A. Banaeiyan et al.
BIOFABRICATION (2017)
Cannabinoid CB1 and CB2 Receptor Signaling and Bias
Mikkel Soes Ibsen et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Novel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro
Sofia B. Leite et al.
BIOMATERIALS (2016)
Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies
Cynthia Ju et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Liver Fibrosis Reversion After Suppression of Hepatitis B Virus
Don C. Rockey
CLINICS IN LIVER DISEASE (2016)
An optimized method for mouse liver sinusoidal endothelial cell isolation
Jeremy Meyer et al.
EXPERIMENTAL CELL RESEARCH (2016)
Cannabinoids, inflammation, and fibrosis
Robert B. Zurier et al.
FASEB JOURNAL (2016)
Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis
Arpan Mohanty et al.
GASTROENTEROLOGY (2016)
Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis
Juan G. Abraldes et al.
GASTROENTEROLOGY (2016)
Atorvastatin and Fluvastatin Are Associated With Dose-Dependent Reductions in Cirrhosis and Hepatocellular Carcinoma, Among Patients With Hepatitis C Virus: Results From ERCHIVES
Tracey G. Simon et al.
HEPATOLOGY (2016)
THE NON-STEROIDAL FXR AGONIST GS-9674 REDUCES LIVER FIBROSIS AND AMELIORATES PORTAL HYPERTENSION IN A RAT NASH MODEL
P. Schwabl et al.
JOURNAL OF HEPATOLOGY (2016)
Sinusoidal communication in liver fibrosis and regeneration
Giusi Marrone et al.
JOURNAL OF HEPATOLOGY (2016)
Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats
Federica Cerini et al.
JOURNAL OF HEPATOLOGY (2016)
Mechanisms of CCl4-induced liver fibrosis with combined transcriptomic and proteomic analysis
Shu Dong et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2016)
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Matthew James Armstrong et al.
LANCET (2016)
FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
Len Verbeke et al.
SCIENTIFIC REPORTS (2016)
Molecular Pathophysiology of Portal Hypertension
Mercedes Fernandez
HEPATOLOGY (2015)
Malnutrition in cirrhosis increases morbidity and mortality
Sudhir Maharshi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension
Rajeshwar P. Mookerjee et al.
JOURNAL OF HEPATOLOGY (2015)
Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments
Jaume Bosch et al.
JOURNAL OF HEPATOLOGY (2015)
Endocannabinoid System Contributes to Liver Injury and Inflammation by Activation of Bone Marrow-Derived Monocytes/Macrophages in a CB1-Dependent Manner
Ping Mai et al.
JOURNAL OF IMMUNOLOGY (2015)
Farnesoid X receptor agonist CDCA reduces blood pressure and regulates vascular tone in spontaneously hypertensive rats
Chenyu Li et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2015)
The carbon tetrachloride model in mice
D. Scholten et al.
LABORATORY ANIMALS (2015)
Arachidonic acid metabolites and endothelial dysfunction of portal hypertension
David Sacerdoti et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2015)
Isolation and Culture of Single Cell Types from Rat Liver
Qidi Zhang et al.
CELLS TISSUES ORGANS (2015)
Isolation, characterization, and cultivation of human hepatocytes and non-parenchymal liver cells
Elisa Pfeiffer et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats
Marc Mejias et al.
GUT (2015)
KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins
Giusi Marrone et al.
GUT (2015)
Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase
Yasuko Iwakiri
CLINICAL AND MOLECULAR HEPATOLOGY (2015)
Angiogenesis and Fibrogenesis in Chronic Liver Diseases
Claudia Bocca et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Pharmacologic Management of Portal Hypertension
Annalisa Berzigotti et al.
CLINICS IN LIVER DISEASE (2014)
Soluble factors derived from human amniotic epithelial cells suppress collagen production in human hepatic stellate cells
Alexander Hodge et al.
CYTOTHERAPY (2014)
A farnesoid X receptor polymorphism predisposes to spontaneous bacterial peritonitis
Philipp Lutz et al.
DIGESTIVE AND LIVER DISEASE (2014)
Coagulopathy in Liver Diseases: Complication or Therapy?
Marcello Bianchini et al.
DIGESTIVE DISEASES (2014)
Statin Use in Patients with Cirrhosis: A Retrospective Cohort Study
Sonal Kumar et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Liver diseases in the elderly
Miguel Bruguera
GASTROENTEROLOGIA Y HEPATOLOGIA (2014)
Roles for Chemokines in Liver Disease
Fabio Marra et al.
GASTROENTEROLOGY (2014)
Vascular Endothelial Growth Factor Promotes Fibrosis Resolution and Repair in Mice
Liu Yang et al.
GASTROENTEROLOGY (2014)
Disruption of Negative Feedback Loop Between Vasohibin-1 and Vascular Endothelial Growth Factor Decreases Portal Pressure, Angiogenesis, and Fibrosis in Cirrhotic Rats
Laura Coch et al.
HEPATOLOGY (2014)
Obeticholic Acid, a Farnesoid X Receptor Agonist, Improves Portal Hypertension by Two Distinct Pathways in Cirrhotic Rats
Len Verbeke et al.
HEPATOLOGY (2014)
Sodium ferulate lowers portal pressure in rats with secondary biliary cirrhosis through the RhoA/Rho-kinase signaling pathway: A preliminary study
Lai Wei et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Effects of fasudil on the portal and systemic hemodynamics of patients with cirrhosis
Takeshi Fukuda et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats
Han-Chieh Lin et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
EFFECTS OF THE FXR AGONIST OBETICHOLIC ACID ON HEPATIC VENOUS PRESSURE GRADIENT (HVPG) IN ALCOHOLIC CIRRHOSIS: A PROOF OF CONCEPT PHASE 2A STUDY
R. Mookerjee et al.
JOURNAL OF HEPATOLOGY (2014)
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats
Philipp Schwabl et al.
JOURNAL OF HEPATOLOGY (2014)
A Novel Modular Bioreactor to In Vitro Study the Hepatic Sinusoid
Xavi Illa et al.
PLOS ONE (2014)
Liver diseases and aging: friends or foes?
Fareeba Sheedfar et al.
AGING CELL (2013)
Leptin receptor blockade reduces intrahepatic vascular resistance and portal pressure in an experimental model of rat liver cirrhosis
Maria Gabriela Delgado et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Double-Blind, Placebo-Controlled Clinical Trial With a Rho-Kinase Inhibitor in Pulmonary Arterial Hypertension - A Pilot Efficacy Trial -
Yoshihiro Fukumoto et al.
CIRCULATION JOURNAL (2013)
Upregulation of thrombomodulin expression by activation of farnesoid X receptor in vascular endothelial cells
Xie He et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Terutroban, a TP-Receptor Antagonist, Reduces Portal Pressure in Cirrhotic Rats
Eugenio Rosado et al.
HEPATOLOGY (2013)
Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats
Maeva Guillaume et al.
JOURNAL OF HEPATOLOGY (2013)
Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats
Marco Di Pascoli et al.
JOURNAL OF HEPATOLOGY (2013)
The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins
Giusi Marrone et al.
JOURNAL OF HEPATOLOGY (2013)
Cannabinoid signaling and liver therapeutics
Ariane Mallat et al.
JOURNAL OF HEPATOLOGY (2013)
The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma - a pilot study
M. Pinter et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Postprandial effects of dark chocolate on portal hypertension in patients with cirrhosis: results of a phase 2, double-blind, randomized controlled trial
Andrea De Gottardi et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
The direct profibrotic and indirect immune antifibrotic balance of blocking the cannabinoid 2 receptor
Yosefa Avraham et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Effects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats
M. D'Amico et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis
Erica Villa et al.
GASTROENTEROLOGY (2012)
Adenoviral dominant-negative soluble PDGFRβ improves hepatic collagen, systemic hemodynamics, and portal pressure in fibrotic rats
V. Reichenbach et al.
JOURNAL OF HEPATOLOGY (2012)
HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects
Sabine Klein et al.
JOURNAL OF HEPATOLOGY (2012)
Functional aspects on the pathophysiology of portal hypertension in cirrhosis
Juan-Carlos Garcia-Pagan et al.
JOURNAL OF HEPATOLOGY (2012)
PPAR alpha activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats
Aina Rodriguez-Vilarrupla et al.
JOURNAL OF HEPATOLOGY (2012)
Asymmetric dimethylarginine (ADMA) determines the improvement of hepatic endothelial dysfunction by vitamin E in cirrhotic rats
Ying-Ying Yang et al.
LIVER INTERNATIONAL (2012)
Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value
Puneeta Tandon et al.
LIVER TRANSPLANTATION (2012)
Human Amniotic Epithelial Cell Transplantation Induces Markers of Alternative Macrophage Activation and Reduces Established Hepatic Fibrosis
Ursula Manuelpillai et al.
PLOS ONE (2012)
Hepatocyte-like cells differentiated from human induced pluripotent stem cells: Relevance to cellular therapies
Yue Yu et al.
STEM CELL RESEARCH (2012)
Prevention of Fibrosis Progression in CCl4-Treated Rats: Role of the Hepatic Endocannabinoid and Apelin Systems
Vedrana Reichenbach et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Liver cirrhosis
Massimo Pinzani et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
Bile Acids Regulate Cardiovascular Function
Sandeep Khurana et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2011)
Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver
Jorge Gracia-Sancho et al.
GUT (2011)
Endocannabinoids in Liver Disease
Joseph Tam et al.
HEPATOLOGY (2011)
The Use of Whole Organ Decellularization for the Generation of a Vascularized Liver Organoid
Pedro M. Baptista et al.
HEPATOLOGY (2011)
Obesity Is an Independent Risk Factor for Clinical Decompensation in Patients with Cirrhosis
Annalisa Berzigotti et al.
HEPATOLOGY (2011)
Cannabinoid CB2 Receptors Protect Against Alcoholic Liver Disease by Regulating Kupffer Cell Polarization in Mice
Alexandre Louvet et al.
HEPATOLOGY (2011)
Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats
Hector Garcia-Caldero et al.
JOURNAL OF HEPATOLOGY (2011)
Angiogenesis in chronic liver disease and its complications
Stephanie Coulon et al.
LIVER INTERNATIONAL (2011)
Proximal tubular injury and rapid formation of atubular glomeruli in mice with unilateral ureteral obstruction: a new look at an old model
Michael S. Forbes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study
Andre Castro Lyra et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Treatment with the Leukotriene Inhibitor Montelukast for 10 Days Attenuates Portal Hypertension in Rat Liver Cirrhosis
Christian J. Steib et al.
HEPATOLOGY (2010)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Old age is associated with ultrastructural changes in isolated rat liver sinusoidal endothelial cells
Jennifer N. O'Reilly et al.
JOURNAL OF ELECTRON MICROSCOPY (2010)
Simvastatin effects on portal-systemic collaterals of portal hypertensive rats
Hui-Chun Huang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Cirrhotic cardiomyopathy
Soren Moller et al.
JOURNAL OF HEPATOLOGY (2010)
Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells
Jonel Trebicka et al.
JOURNAL OF HEPATOLOGY (2010)
Network Analysis of Primary Hepatocyte Dedifferentiation Using a Shotgun Proteomics Approach
Cliff Rowe et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis
Paolo Caraceni et al.
LIVER INTERNATIONAL (2010)
Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix
Basak E. Uygun et al.
NATURE MEDICINE (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Natural taurine promotes apoptosis of human hepatic stellate cells in proteomics analysis
Xin Deng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Extracellular matrix as a biological scaffold material: Structure and function
Stephen F. Badylak et al.
ACTA BIOMATERIALIA (2009)
Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis
M. Hennenberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
An Imbalance of Pro- vs Anti-Coagulation Factors in Plasma From Patients With Cirrhosis
Armando Tripodi et al.
GASTROENTEROLOGY (2009)
Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
Juan G. Abraldes et al.
GASTROENTEROLOGY (2009)
Beneficial Effects of Sorafenib on Splanchnic, Intrahepatic, and Portocollateral Circulations in Portal Hypertensive and Cirrhotic Rats
Marc Mejias et al.
HEPATOLOGY (2009)
Pan-Caspase Inhibitor VX-166 Reduces Fibrosis in an Animal Model of Nonalcoholic Steatohepatitis
Rafal P. Witek et al.
HEPATOLOGY (2009)
Microenvironmental Regulation of the Sinusoidal Endothelial Cell Phenotype In Vitro
Sandra March et al.
HEPATOLOGY (2009)
Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-κB-dependent pathways
Joy X. Jiang et al.
JOURNAL OF HEPATOLOGY (2009)
Angiogenesis in liver disease
Mercedes Fernandez et al.
JOURNAL OF HEPATOLOGY (2009)
Vascularization Strategies for Tissue Engineering
Michael Lovett et al.
TISSUE ENGINEERING PART B-REVIEWS (2009)
Attenuation of portal hypertension by natural taurine in rats with liver cirrhosis
Jian Liang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver
A. Mallat et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
CB2 receptors as new therapeutic targets for liver diseases
S. Lotersztajn et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Placenta-derived stem cells: new hope for cell therapy?
Marco Evangelista et al.
CYTOTECHNOLOGY (2008)
Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells
Frank A. Schildberg et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Hepatic Stellate Cells Secrete Angiopoietin 1 That Induces Angiogenesis in Liver Fibrosis
Kojiro Taura et al.
GASTROENTEROLOGY (2008)
Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation
Anja M. Geerts et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2008)
Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis
Ying-Ying Yang et al.
JOURNAL OF HEPATOLOGY (2008)
Concise review:: Isolation and characterization of cells from human term placenta:: Outcome of the first international workshop on placenta derived stem cells
Ornella Parolini et al.
STEM CELLS (2008)
Increased oxidative stress in cirrhotic rat livers:: A potential mechanism contributing to reduced nitric oxide bioavailability
Jorge Gracia-Sancho et al.
HEPATOLOGY (2008)
Defective endothelial nitric oxide synthase signaling is mediated by rho-kinase activation in rats with secondary biliary cirrhosis
Go Anegawa et al.
HEPATOLOGY (2008)
Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats
Snia Tugues et al.
HEPATOLOGY (2007)
Orally-administered caspase inhibitor PF-03491390 is retained in the liver for prolonged periods with low systemic exposure, exerting a hepatoprotective effect against α-Fas-induced liver injury in a mouse model
Yoshinobu Ueno et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2007)
Evidence against a role for NADPH oxidase modulating hepatic vascular tone in cirrhosis
Jorge Gracia-Sancho et al.
GASTROENTEROLOGY (2007)
Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A2
Christian J. Steib et al.
JOURNAL OF HEPATOLOGY (2007)
Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers
Jorge Gracia-Sancho et al.
JOURNAL OF HEPATOLOGY (2007)
Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase
Jonel Trebicka et al.
HEPATOLOGY (2007)
Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats
Juan G. Abraldes et al.
JOURNAL OF HEPATOLOGY (2007)
A caspase inhibitor, IDN-6556, ameliorates early hepatic injury in an ex vivo rat model of warm and cold ischemia
Niel C. Hoglen et al.
LIVER TRANSPLANTATION (2007)
Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats
Wim Laleman et al.
GASTROENTEROLOGY (2007)
Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy
Shuji Terai et al.
STEM CELLS (2006)
Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis
Q. Zhou et al.
GUT (2006)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis
Vasilica Matei et al.
HEPATOLOGY (2006)
Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state
JG Abraldes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats
M Hennenberg et al.
GASTROENTEROLOGY (2006)
Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension
M Hernández-Guerra et al.
HEPATOLOGY (2006)
The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule
Y Iwakiri et al.
HEPATOLOGY (2006)
Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2
KM Parmar et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Anti-inflammatory effects of statins: Clinical evidence and basic mechanisms
MK Jain et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Statins exert endothelial atheroprotective effects via the KLF2 transcription factor
KM Parmar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The role of nitric oxide in the pathogenesis of systemic and splanchnic vasodilation in cirrhotic rats before and after the onset of ascites
P Angeli et al.
LIVER INTERNATIONAL (2005)
Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers
M Graupera et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
B Julien et al.
GASTROENTEROLOGY (2005)
Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis
C Zafra et al.
GASTROENTEROLOGY (2004)
The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse
A Canbay et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Vascular hyporesponsiveness in the mesenteric artery of anaesthetized rats with cirrhosis and portal hypertension: an in-vivo study
IO Colle et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2004)
Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation
LD DeLeve et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
The endocannabinoid system and its therapeutic exploitation
V Di Marzo et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Rho modulates hepatic sinusoidal endothelial fenestrae via regulation of the actin cytoskeleton in rat endothelial cells
H Yokomori et al.
LABORATORY INVESTIGATION (2004)
Dominant-negative soluble PDGF-β receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis
E Borkham-Kamphorst et al.
LABORATORY INVESTIGATION (2004)
A role for thrombin in liver fibrosis
JG Duplantier et al.
GUT (2004)
Expression of leptin and leptin receptor during the development of liver fibrosis and cirrhosis
C Otte et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2004)
Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression
A Canbay et al.
HEPATOLOGY (2003)
Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers
M Graupera et al.
JOURNAL OF HEPATOLOGY (2003)
Hepatic sinusoidal pseudocapillarization with aging in the non-human primate
VC Cogger et al.
EXPERIMENTAL GERONTOLOGY (2003)
Therapeutic significance of Y-27632, a Rho-kinase inhibitor, on the established liver fibrosis
T Murata et al.
JOURNAL OF SURGICAL RESEARCH (2003)
Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats
M Morales-Ruiz et al.
GASTROENTEROLOGY (2003)
Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats
V Lorenzo-Zúñiga et al.
HEPATOLOGY (2003)
Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel-like factor (KLF2)
RJ Dekker et al.
BLOOD (2002)
Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells
PA Knolle et al.
TRENDS IN IMMUNOLOGY (2001)
Thrombin responses in human endothelial cells - Contributions from receptors other than Par1 include the transactivation of Par2 by thrombin-cleaved Par1
PJ O'Brien et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A p160ROCK-specific inhibitor, Y-27632, attenuates rat hepatic stellate cell growth
H Iwamoto et al.
JOURNAL OF HEPATOLOGY (2000)
Hepatocyte-derived cysteinyl leukotrienes modulate vascular tone in experimental cirrhosis
E Titos et al.
GASTROENTEROLOGY (2000)
分享论文
